Role of Activin A and myostatin in human cancer cachexia

The Journal of Clinical Endocrinology and Metabolism
Audrey LoumayeJean-Paul Thissen

Abstract

Cachexia is a multifactorial syndrome, characterized by the loss of skeletal muscle mass and not fully reversible by nutritional support. Recent animal observations suggest that production of Activin A (ActA) and Myostatin (Mstn) by some tumors might contribute to cancer cachexia. Our goal was to investigate the role of ActA and Mstn in the development of the human cancer cachexia. The ACTICA study is a cross-sectional study, which prospectively enrolled patients from a tertiary-care center between January 2012 and March 2014. Subjects/Outcome Measures: One hundred fifty two patients with colorectal or lung cancer had clinical, nutritional and functional assessment. Body composition was measured by CT-scan, anthropometry, and bioimpedance. Plasma concentrations of ActA, Mstn, and Follistatin were determined. Cachexia was associated with reduced lean and fat mass (p < .01 and p < .001), reduced physical function, lower quality of life, and increased symptoms (QLQC30; p < .001). Anorexia (SNAQ score < 14) was more common in cachectic patients (CC) than in noncachectic patients (CNC) (p < .001). ActA concentrations in CC patients were higher than in CNC patients (+40%; p < .001) and were correlated positively with weight loss (R =...Continue Reading

Associated Clinical Trials

Citations

Feb 18, 2016·Human Reproduction Update·R Wijayarathna, D M de Kretser
Feb 11, 2016·Seminars in Cell & Developmental Biology·Teresa A ZimmersAndrea Bonetto
Dec 29, 2015·Free Radical Biology & Medicine·Mohamad AssiAmélie Rébillard
Jan 20, 2016·Seminars in Cell & Developmental Biology·Iain J GallagherKenneth Fearon
Feb 24, 2016·Oncogenesis·P E Porporato
Nov 8, 2015·International Journal of Cardiology·Goran LoncarMitja Lainscak
Mar 16, 2016·Journal of Experimental & Clinical Cancer Research : CR·Xiu-yan HuangZhou Yuan
Nov 14, 2015·Seminars in Cell & Developmental Biology·Marco Sandri
Jun 27, 2015·The Journal of Endocrinology·Maria Carolina S MendesJosé B C Carvalheira
Jul 8, 2016·Journal of Cachexia, Sarcopenia and Muscle·Jens Fielitz
Jul 8, 2016·Journal of Cachexia, Sarcopenia and Muscle·Goran LoncarMitja Lainscak
Oct 25, 2016·Gastroenterology·Barbara JungDaniel Beauchamp
Jan 12, 2017·Clinical and Experimental Pharmacology & Physiology·Yu-Si ChenTie-Jian Jiang
Jul 18, 2017·Journal of Cachexia, Sarcopenia and Muscle·Audrey LoumayeJean-Paul Thissen
Nov 11, 2017·Journal of Applied Physiology·Brandon N VanderVeenJames A Carson
Aug 17, 2018·Pancreas·Sally E HendersonThomas A Mace
Nov 27, 2018·Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society·C WallnerB Behr
Jan 19, 2018·Nature Reviews. Disease Primers·Vickie E BaracosKenneth C H Fearon
Nov 7, 2019·International Journal of Molecular Sciences·Rami ArchidRobert B Wilson
Dec 11, 2019·Cancers·Anirban Roy, Ashok Kumar
May 3, 2018·Oncotarget·Laure B BindelsNathalie M Delzenne
Feb 9, 2017·Oncotarget·Henrique L CoutoFernando M Reis
Jul 12, 2020·Physiological Reports·Athan G DialThomas J Hawke
Apr 30, 2017·Nature Communications·Esther LatresJesper Gromada
Apr 30, 2017·Frontiers in Microbiology·Naina AroraAmit Prasad
Jul 10, 2019·Journal of Cachexia, Sarcopenia and Muscle·Xiaoling ZhongTeresa A Zimmers
Jan 8, 2020·World Journal of Gastrointestinal Oncology·Livia PetruselAndrada Seicean
Sep 10, 2020·JCSM Rapid Communications·Paige C Arneson-WissinkJason D Doles
Sep 16, 2020·International Journal of Environmental Research and Public Health·Myong-Won SeoJong Kook Song
Aug 9, 2017·Oxidative Medicine and Cellular Longevity·Brandon N VanderVeenJames A Carson
Jul 22, 2016·Science Translational Medicine·Catherine E WinbanksPaul Gregorevic
May 1, 2018·The Proceedings of the Nutrition Society·Dalton L Schiessel, Vickie E Baracos
Jul 24, 2020·Expert Opinion on Therapeutic Targets·Alexander RiesMichael Grusch
Nov 2, 2017·Scientific Reports·Rafael BarretoAndrea Bonetto
Jul 6, 2019·Journal of Cachexia, Sarcopenia and Muscle·Joanna D C C LimaMarilia Seelaender
Aug 24, 2019·The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·Min Kyu Jung
Dec 13, 2019·BMC Nephrology·Pasquale EspositoTeresa Rampino

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Related Papers

Annales d'endocrinologie
Jean-Paul Thissen, Audrey Loumaye
Pneumonologia i alergologia polska
Bozena WeryńskaRenata Jankowska
Vitamins and Hormones
Bobby GuilloryJose Garcia
The Cancer Journal
Marie-France Penet, Zaver M Bhujwalla
© 2022 Meta ULC. All rights reserved